CytoMed Therapeutics Limited Interest Paid Classified As Financing Activities
CytoMed Therapeutics Limited (GDTC) reported Interest Paid Classified As Financing Activities of SGD 20.91 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:InterestPaidClassifiedAsFinancingActivities · last filed 2026-03-31
SGD
| Period end | Interest Paid Classified As Financing Activities 12 month |
|---|---|
| 2025-12-31 | 20.91K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 20.31K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 46.71K SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 125.17K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 117.70K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 105.52K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Interest Paid Classified As Financing Activities 12 month |
|---|---|
| 2025-12-31 | $16.26K 20-F · filed 2026-03-31 |
| 2024-12-31 | $14.87K 20-F · filed 2025-04-28 |
| 2023-12-31 | $35.41K 20-F · filed 2024-04-22 |
| 2022-12-31 | $93.39K 20-F · filed 2023-05-01 |